James E. Flynn, Director: Larimar Therapeutics LRMR Buy · Filed 25/08/04

Trade details

Type: Insider buy
Amount: $8,319,782.4
Shares · price: 2,599,932 sh · $3.20 a share
Held after: 7,321,129 sh
Stock: Larimar Therapeutics LRMR
Person: James E. FlynnDirector
Trade date: 25/07/31
Filed: 25/08/04
Days to filing: 4 days

First buy in 1 years

Since the last buy: 1.5 years
Last buy: 24/02/16
Insiders buying this week: 10 insiders
Holding change: +55.1%

Larimar Therapeutics trades, last 26 weeks

What else happened in Larimar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/01~25/08/30

James E. Flynn's recent trades

James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$10M
2,000,000 sh
$10M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,012 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,010 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$4.2M
831,978 sh
$4.2M
Filed 03/02
Traded 02/27
James E. FlynnDirector
SellNuvalent
Sell
Nuvalent
NUVL
$35.4M
371,287 sh
$35.4M
Filed 25/11/24
Traded 25/11/24

James E. Flynn, Director — bought $8.3M of Larimar Therapeutics LRMR · 2,599,932 sh @ $3.20 | Whalegun